By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NeuroDerm Ltd. 

Ofakim      Israel
Phone: 925-270-0519 Fax: 925-290-1209



Company News
NeuroDerm (NDRM) Announces First Quarter 2015 Financial Results And Provides Corporate Update 5/27/2015 7:47:43 AM
NeuroDerm (NDRM) CEO To Present At Jefferies and Co. 2015 Healthcare Conference On June 1, 2015 5/26/2015 7:42:24 AM
NeuroDerm (NDRM) To Host First Quarter 2015 Financial Results Conference Call On May 27, 2015 5/20/2015 11:46:52 AM
FDA Lifts Clinical Hold on NeuroDerm (NDRM)'s Lead Parkinson's Candidates 5/8/2015 6:11:33 AM
NeuroDerm Ltd. (NDRM) Files Annual Report On Form 20-F For The Year Ended December 31, 2014 4/29/2015 7:33:15 AM
NeuroDerm Ltd. (NDRM) Announces Fourth Quarter And 2014 Fiscal Year Financial Results And Provides A Corporate Update 4/2/2015 7:23:56 AM
NeuroDerm Ltd. (NDRM) To Announce Updated Topline Results Of Phase II Study Of Continuous, Subcutaneously-Delivered Levodopa/Carbidopa For The Treatment Of Parkinson's Disease At The 67th Annual Meeting Of The American Academy of Neurology 4/1/2015 6:10:40 AM
NeuroDerm Ltd. (NDRM) CEO To Present At Upcoming Investor Conferences 2/24/2015 9:00:09 AM
NeuroDerm Ltd. (NDRM) Announces Extraordinary General Meeting Of Shareholders For Ratification Of Election Of External Directors And Adoption Of Compensation Policy 1/20/2015 6:03:08 AM
NeuroDerm Ltd. (NDRM) Announces Topline Results Of Phase 2a Pharmacokinetic Study Of ND0612H And ND0612L, Continuous, Subcutaneously Delivered Levodopa/Carbidopa For The Treatment Of Parkinson's Disease 12/31/2014 6:41:09 AM